Warby Parker Inc.
Close on Oct 19, 2026
- Market cap
- $3.14B
- P/E (TTM)
- 357.0
- Dividend yield
- –
About Warby Parker
Ophthalmic Goods, SIC 3851
Warby Parker designs and retails prescription eyewear, sunglasses, contact lenses, and related vision care products. The company provides optometric services, including in-person eye examinations, telehealth prescription renewals through its mobile application, and lens replacement options. It operates through an omnichannel model that combines digital e-commerce platforms with physical retail locations. Customers comprise individual retail consumers and vision care patients, including individuals utilizing vision insurance benefits.
The company is headquartered in New York City, where it conducts product design. Its operational footprint includes 323 retail stores across the United States and Canada, two corporate offices in the United States, and two optical laboratories located in Sloatsburg, New York, and Las Vegas, Nevada. Warby Parker employs over 4,000 workers and maintains a global supply network with manufacturing partners in China, Japan, Vietnam, Italy, and Thailand.
Summary of the business section of Warby Parker's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Warby Parker Inc.
- Founded
- 2010
- Headquarters
- New York, NY
- Address
- 233 Spring Street, 6th Floor East 10013
- Phone
- (646) 847-7215
- Website
- warbyparker.com
- Employees
- 4,036, Dec 31, 2025
- Industry
- Ophthalmic Goods
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, New York, New York
Stock & identifiers
- Ticker
- WRBY
- Exchange
- NYSE
- IPO date
- Sep 29, 2021
- Shares outstanding
- 124M, Aug 4, 2026
- Public float
- $2.17B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1504776
- CUSIP
- 93403J106
- ISIN
- US93403J1060
- EIN
- 80-0423634
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| David Abraham Gilboa | Co-Chief Executive Officer, Director | 6,285,087 |
| Neil Harris Blumenthal | Co-Chief Executive Officer, Director | 7,737,721 |
| Adrian V. Mitchell | Chief Financial Officer | – |
| Steven Clive Miller | Chief Financial Officer | 233,123 |
| Jeffrey Jacob Raider | Director | 3,897,898 |
| Teresa Briggs | Director | 64,852 |
| Youngme E. Moon | Director | 26,061 |
| Bradley E. Singer | Director | 125,030 |
| Ronald A. Williams | Director | 122,802 |
| Andrew Hunt | Director | 1,941,236 |
| Joel E. Cutler | Director | 220,084 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Blumenthal | $9.00M | -$5.73M | $2.59M | $40 | $107 |
| FY2025 Gilboa | $9.00M | -$5.74M | $2.59M | $40 | $107 |
| FY2024 Blumenthal | $1.48M | $22.43M | $3.23M | $44 | $94 |
| FY2024 Gilboa | $1.48M | $22.43M | $3.23M | $44 | $94 |
| FY2023 Blumenthal | $907.14K | $2.90M | $2.79M | $26 | $96 |
| FY2023 Gilboa | $907.14K | $2.90M | $2.79M | $26 | $96 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had a total of 4,036 employees, including 2,275 full-time employees and 1,761 part-time employees, across 323 retail stores, two in-house optical laboratories, and two offices in the United States.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Sep 29, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Sep 21, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
| Mar 23, 2018 | Name change | Name changed from JAND, Inc. to Warby Parker Inc. |